Just diagnosed with Pigmentary pallidal degeneration?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Pigmentary pallidal degeneration, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Pigmentary pallidal degeneration hub →Overview
Pigmentary pallidal degeneration is a rare condition. Also known as Hallervorden-Spatz syndrome, NBIA1, Neurodegeneration with brain iron accumulation type 1, PKAN. Tomeko brings together the specialists, research, clinical trials, treatments and community for Pigmentary pallidal degeneration so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:157850 · OMIM 234200 · ICD-10 G23.0 · GARD 0006564
Find care for Pigmentary pallidal degeneration
Authoritative references for Pigmentary pallidal degeneration
Research & market landscape for Pigmentary pallidal degeneration
Following Pigmentary pallidal degeneration for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Pigmentary pallidal degeneration — the real-world landscape behind the condition, in one place.
- Latest Pigmentary pallidal degeneration research on PubMed ↗
- Recruiting Pigmentary pallidal degeneration trials on ClinicalTrials.gov ↗
- Explore the Pigmentary pallidal degeneration research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Pigmentary pallidal degeneration and every rare condition. See how Tomeko works with industry →
Common questions
What is Pigmentary pallidal degeneration?
Pigmentary pallidal degeneration is a rare condition. Also known as Hallervorden-Spatz syndrome, NBIA1, Neurodegeneration with brain iron accumulation type 1, PKAN. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Pigmentary pallidal degeneration together in one place.
What are the symptoms of Pigmentary pallidal degeneration?
Symptoms of Pigmentary pallidal degeneration vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Pigmentary pallidal degeneration.
How is Pigmentary pallidal degeneration treated?
Treatment for Pigmentary pallidal degeneration depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Pigmentary pallidal degeneration, and review current options with them.
What causes Pigmentary pallidal degeneration — is it genetic?
The cause and inheritance of Pigmentary pallidal degeneration are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Pigmentary pallidal degeneration can explain what it means for you and your family.
I was just diagnosed with Pigmentary pallidal degeneration — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Pigmentary pallidal degeneration, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Pigmentary pallidal degeneration?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Pigmentary pallidal degeneration, filtered to your area.
Are there clinical trials for Pigmentary pallidal degeneration?
Tomeko shows live, recruiting studies for Pigmentary pallidal degeneration from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acetazolamide-responsive myotonia
- Acquired porencephaly
- Actin accumulation myopathy
- Action myoclonus-renal failure syndrome
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute encephalopathy with biphasic seizures and late reduced diffusion